OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $224,000 | -2.2% | 71,489 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $229,000 | -39.1% | 71,489 | -36.2% | 0.01% | -50.0% |
Q3 2021 | $376,000 | -32.0% | 112,044 | -20.8% | 0.01% | -44.4% |
Q2 2021 | $553,000 | +4.3% | 141,433 | +7.3% | 0.02% | -10.0% |
Q1 2021 | $530,000 | +204.6% | 131,834 | +125.9% | 0.02% | +42.9% |
Q1 2020 | $174,000 | -44.6% | 58,368 | -22.9% | 0.01% | -48.1% |
Q4 2019 | $314,000 | +22.2% | 75,738 | -4.6% | 0.03% | +12.5% |
Q3 2019 | $257,000 | – | 79,395 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |